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Patients who survive critical illness sometimes report poor health-related quality of life 
(HRQoL)(1), but rehabilitation trials have mostly found no effect on this and other measures 
of health status (2–5). Most critical care research has employed tools such as the Medical 
Outcomes Study Short Form questionnaires (SF12/SF36) or EuroQol (EQ-5D) to measure 
HRQoL.(6) Although validated in general and other disease-defined cohorts, these generic 
patient-reported outcome measures may miss issues important to critical illness survivors. 
The use of specific symptoms associated with critical illness survivorship may improve our 
understanding of the burden of critical illness, and are not widely reported in the critical 
care literature (7).  
In an ICU rehabilitation trial  (RECOVER), we found no effect of the intervention on 
functional status, HRQoL and a range of other outcomes during 12 months follow-up (4). In 
a secondary analyses we aimed to describe trajectories of appetite, fatigue, pain, joint 
stiffness, and breathlessness symptoms that pre-trial pilot work identified as important to 
patients. We also aimed to examine the correlation between symptoms and generic HRQoL 
metrics. 
As there were no inter-group differences in symptoms in the RECOVER trial, patients were 
analysed as a single cohort.  Symptom data was available for 189/228 (83%), 166/220 (75%), 
and 161/218 (76%) of surviving patients at 3, 6, and 12 months respectively.   
Symptoms (appetite, fatigue, pain, joint stiffness and breathlessness) were measured on a 
visual analogue scale (VAS) of 10cm in length ranging from 0 (no symptoms at all) to 10 
(worse symptoms imaginable). Mean scores (and 95% confidence intervals) and frequency 
of patients with mild, moderate, and severe symptoms (scores of 0-3.3; 3.4-6.6; 6.7-10) 
were calculated at for each time point.  Comparisons between 3 month symptoms and 12 
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month symptoms for complete cases was made with paired t tests.  Pearson correlation 
coefficients between symptoms and HRQoL (SF12v2 Physical Component Score (PCS) and 
Mental Component Score (MCS)) were calculated. 
Symptom scores and severity category frequencies are shown in table 1.  At ICU discharge 
fatigue and joint stiffness had the highest mean (standard deviation (SD)) scores (4.9(2.6) 
and 4.1(2.9) respectively) and more patients reported these symptoms as severe than other 
symptoms (30% and 25% respectively). Statistically significant improvements in pain, joint 
stiffness, and breathlessness were noted between 3 andd 12 months but clinically, these 
differences were small (less that a single centimetre on the VAS).  At 12 months, there 
remained a significant proportion of patients experiencing symptoms at the most severe 
end of each symptom scale (table 1).  
Symptoms correlated with PCS at 12 months (r (± 95% CI): appetite -0.37 (-0.23 to - 0.50), 
fatigue -0.61 (-0.69 to -0.52), pain -0.66 (-0.75 to -0.56), joint stiffness -0.64 (-0.73 to -0.54), 
breathlessness -0.44 (-0.57 to -0.30)) (table 2). Symptoms and MCS were also correlated, 
with strongest relationships observed for pain ( -0·42 (-0.56 to -0.29)) and fatigue (-0·46 (-
0.57 to -0.34)). 
Previous investigators have shown that HRQoL is reduced following critical illness and that 
spontaneous improvement is limited, sometimes over many years (1). Some (but not all) 
rehabilitation trials have demonstrated improved functional outcomes, but have not 
necessarily improved HRQoL (4,5). In this analysis, we have shown that symptoms that 
influence daily life are prevalent following ICU discharge,  are highly correlated with HRQoL, 
and frequently worsen in their severity over time.  
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Limitations of our study, include its small sample size (from one region of Scotland) which 
may limit generalisability to other healthcare settings.   Whilst patients with missing data 
appeared similar at baseline, justifying the complete case approach, we cannot completely 
exclude bias arising from excluded patients.  Finally, we were unable to assess effects of re-
hospitalisation after critical illness which may have been more likely in multiply comorbid 
patients and could have contributed to ongoing symptoms.   
Future research should consider including symptoms as outcome measures, since these may 
enrich the description of post-ICU health status.  
The authors confirm that there are no conflicts of interest in relation to the submitted work. 
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Table 1 – Symptom severity at 3, 6, and 12 months for all available patients. Measured by 
visual analogue scale 0-10 with 10 being most severe including appetite where 10 
represents poorest appetite.  Severity categories are mild (0-3.3); moderate (3.4-6.6) and 
severe (6.7-10).  *For patients with data at both time points, mean of the paired differences 
(3-12 months) was calculated for each symptom.  Paired t tests were used to compare the 3 
and 12-month time points. 
    
3 months 6 months 12 months 
Mean (95% CI) 
difference between 
3 and 12 months* 
P value* 
    
APPETITE n 188 166 157 155  
 Mean 3.6 3.4 3.4 0.2 (-0.2 to 0.7) 0.311 
 SD 3.0 2.5 2.6 
  
 Mild 110 (59%) 97 (58%) 93 (59%)   
 Moderate 39 (21%) 49 (30%) 44 (28%)   
 Severe 39 (21%) 20 (12%) 20 (13%)   
  
   
  
FATIGUE n 188 166 159 145  
 Mean 4.9 5.3 5.2 -0.3 (-0.8 to 0.1) 0.163 
 SD 2.6 2.7 2.7 
  
 Mild 57 (30%) 40(20%) 49 (31%) 
  
 Moderate 74 (39%) 65 (39%) 55 (35%) 
  
 Severe 57 (30%) 61 (37%) 55(35%) 
  
  
   
  
PAIN n 188 167 161 146  
 Mean 3.6 4.1 3.9 -0.5 (-1.0 to -0.1) 0.030 
 SD 2.9 3.1 3.1 
  
 Mild 96 (51%) 71 (43%) 78 (48%) 
  
 Moderate 58 (31%) 52 (31%) 40 (25%) 
  
 Severe 34 (18%) 44 (26%) 43 (27%) 
  
  
   
  
JOINT STIFFNESS n 188 167 156 143  
 Mean 4.1 4.6 4.8 -0.9 (-1.3 to -0.4) <0.001 
 SD 2.9 2.9 2.9 
  
 Mild 83 (44%) 64 (38%) 50 (32%) 
  
 Moderate 58 (31%) 52 (31%) 56 (36%) 
  
 Severe 47 (25%) 51 (31%) 50 (32%) 
  
  
   
  
BREATHLESSNESS n 189 167 161 146  
 Mean 3.3 3.7 3.7 -0.6 (-1.0 to -0.1) 0.019 
 SD 2.6 2.7 2.8 
  
 Mild 106 (56%) 81 (49%) 81 (50%) 
  
 Moderate 57 (30%) 59 (35%) 48 (30%) 
  
 Severe 26 (14%) 27 (16%) 32 (20%) 
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Table 2 – Pearson correlation between symptom scores and SF12 version 2 physical 
component score (PCS) and mental component score (MCS) at 3, 6 and 12 months.  P values 
are 2 tailed.  Abbreviations: n: sample size; r: Pearson’s correlation coefficient. 
 
  
  
PCS MCS 
  3 months 6 months 12 months 3 months 6 months 12 months 
APPETITE n 188 163 152 188 163 152 
 r -0.280 -0.328 -0.365 -0.317 -0.292 -0.299 
 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
       
FATIGUE n 188 163 154 188 163 154 
 
r -0.382 -0.522 -0.606 -0.435 -0.567 -0.457 
 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
       
PAIN n 188 164 155 188 164 155 
 
r -0.536 -0.580 -0.660 -0.343 -0.514 -0.419 
 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
       
JOINT  
STIFFNESS 
n 
188 164 151 
188 164 151 
 r -0.377 -0.464 -0.643 -0.189 -0.375 -0.378 
 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
       
BREATHLESS n 189 164 155 189 164 155 
 r -0.271 -0.374 -0.442 -0.323 -0.364 -0.293 
 
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
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